ArticleJournal of applied clinical medical physics2025
Feasibility of segmental total body irradiation (SegTBI) using a 1.5T MR-linac.
Article in Journal of applied clinical medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Feasibility of segmental total body irradiation (SegTBI) using a 1.5T MR-linac.Journal of applied clinical medical physics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the technical feasibility of using the elekta unity magnetic resonance linac (MRL) as a backup for tomotherapy in total body irradiation (TBI) treatment.
methodsA single pediatric patient's TBI treatment with a prescription of 12 Gy in six fractions was retrospectively re-planned using a multiple-isocentre approach with dose feathering on the MRL system. An additional plan was created and delivered to an anthropomorphic phantom containing OSLDs. The study investigated the MRL system's limitations and capabilities.
resultsThe plan sum of the nine segments not only met the dosimetric criteria of planning targets but also demonstrated the MRL system's capabilities by keeping the mean lung dose below 8 Gy and the mean kidney dose below 10 Gy. The electron streaming effect was observed. Treatment plan verification using ArcCHECK measurements with a global 3%/2 mm gamma analysis had a pass rate greater than 95% for all segments. In 28 out of the 30 OSLDs in brain, bone, and soft tissues, the deviation of the measurement from the reported TPS dose is within ±5%. A much larger deviation was observed in the lung tissues. Segmental TBI using the MRL was a viable option for TBI treatment. SIGNIFICANCE: This study demonstrates the technical feasibility of MRL for TBI by offering dose modulation and imaging capabilities. The MRL can serve as a backup despite longer planning and treatment times. The potential for future workflow optimizations could enhance its practicality. This research improves flexibility in treatment planning and delivery for TBI patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.